---
figid: PMC4359552__12986_2015_1_Fig1_HTML
figtitle: Conceptual model of general lifestyle effects, salient CHD pathogenetic
  pathways and CHD hallmarks
organisms:
- Porphyromonas gingivalis
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4359552
filename: 12986_2015_1_Fig1_HTML.jpg
figlink: /pmc/articles/PMC4359552/figure/Fig1/
number: F1
caption: Conceptual model of general lifestyle effects, salient CHD pathogenetic pathways
  and CHD hallmarks. The affective pathway of pharmacotherapeutics, blue boxes, is
  shown in Figure 1, and salient serological biomarkers are indicated by the  icon.
  The blunted blue arrows denote antagonise or inhibit and pointed blue arrows denote
  up-regulate or facilitate. HDL denotes high-density lipoprotein; LDL, low-density
  lipoprotein; oxLDL, oxidised LDL; FFA, free fatty acids; TMAO, an oxidation product
  of trimethylamine (TMA); NLRP3, Inflammasome responsible for activation of inflammatory
  processes as well as epithelial cell regeneration and microflora; Hs, homocysteine;
  IGF-1, insulin-like growth factor-1; TNF-α , tumour necrosis factor-α; IL, interleukin;
  NO, nitric oxide; NO-NSAIDs, combinational NO-non-steroidal anti-inflammatory drug;
  SSRI, serotonin reuptake inhibitors; ROS, reactive oxygen species; NFκβ, nuclear
  factor-κβ; SMC, smooth muscle cell; HbA1c, glycosylated haemoglobin A1c; P. gingivalis,
  Porphyromonas gingivalis; vWF, von Willebrand factor; PDGF, platelet-derived growth
  factor; MIF, macrophage migration inhibitory factor; SCD-40, recombinant human sCD40
  ligand; MPO, myeloperoxidase; MMP, matrix metalloproteinase; VCAM, vascular cell
  adhesion molecule; ICAM, intracellular adhesion molecule; CRP, C-reactive protein;
  PAI, plasminogen activator inhibitor; TF, tissue factor, MCP, monocyte chemoattractant
  protein; BDNF, brain-derived neurotrophic factor; PI3K, phosphatidylinositol 3-kinase;
  MAPK, mitogen-activated protein (MAP) kinase; RANKL, receptor activator of nuclear
  factor kappa-beta ligand; OPG, osteoprotegerin; GCF, gingival crevicular fluid;
  D-dimer, fibrin degradation product D; BNP, B-type natriuretic peptide; ACE, angiotensin-converting-enzyme;
  COX, cyclooxygenase; β-blocker, beta-adrenergic antagonists.
papertitle: How do high glycemic load diets influence coronary heart disease?.
reftext: Marc J Mathews, et al. Nutr Metab (Lond). 2015;12:6.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9490671
figid_alias: PMC4359552__F1
figtype: Figure
redirect_from: /figures/PMC4359552__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4359552__12986_2015_1_Fig1_HTML.html
  '@type': Dataset
  description: Conceptual model of general lifestyle effects, salient CHD pathogenetic
    pathways and CHD hallmarks. The affective pathway of pharmacotherapeutics, blue
    boxes, is shown in Figure 1, and salient serological biomarkers are indicated
    by the  icon. The blunted blue arrows denote antagonise or inhibit and pointed
    blue arrows denote up-regulate or facilitate. HDL denotes high-density lipoprotein;
    LDL, low-density lipoprotein; oxLDL, oxidised LDL; FFA, free fatty acids; TMAO,
    an oxidation product of trimethylamine (TMA); NLRP3, Inflammasome responsible
    for activation of inflammatory processes as well as epithelial cell regeneration
    and microflora; Hs, homocysteine; IGF-1, insulin-like growth factor-1; TNF-α ,
    tumour necrosis factor-α; IL, interleukin; NO, nitric oxide; NO-NSAIDs, combinational
    NO-non-steroidal anti-inflammatory drug; SSRI, serotonin reuptake inhibitors;
    ROS, reactive oxygen species; NFκβ, nuclear factor-κβ; SMC, smooth muscle cell;
    HbA1c, glycosylated haemoglobin A1c; P. gingivalis, Porphyromonas gingivalis;
    vWF, von Willebrand factor; PDGF, platelet-derived growth factor; MIF, macrophage
    migration inhibitory factor; SCD-40, recombinant human sCD40 ligand; MPO, myeloperoxidase;
    MMP, matrix metalloproteinase; VCAM, vascular cell adhesion molecule; ICAM, intracellular
    adhesion molecule; CRP, C-reactive protein; PAI, plasminogen activator inhibitor;
    TF, tissue factor, MCP, monocyte chemoattractant protein; BDNF, brain-derived
    neurotrophic factor; PI3K, phosphatidylinositol 3-kinase; MAPK, mitogen-activated
    protein (MAP) kinase; RANKL, receptor activator of nuclear factor kappa-beta ligand;
    OPG, osteoprotegerin; GCF, gingival crevicular fluid; D-dimer, fibrin degradation
    product D; BNP, B-type natriuretic peptide; ACE, angiotensin-converting-enzyme;
    COX, cyclooxygenase; β-blocker, beta-adrenergic antagonists.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BDNF
  - BDNF-AS
  - NES
  - TNF
  - HSD11B1
  - ALB
  - APOA1
  - APOA2
  - APOE
  - CLU
  - NLRP3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - FGA
  - FGB
  - FGG
  - MIF
  - AMH
  - S100A8
  - S100A9
  - CCL2
  - TNFSF11
  - SELE
  - SELL
  - SELP
  - TF
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - ICAM1
  - ICAM2
  - ICAM3
  - ICAM4
  - ICAM5
  - VCAM1
  - CXCL8
  - IL6
  - DYM
  - ACE
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - OPRD1
  - TP53INP2
  - PTGS2
  - MPO
  - IGF1
  - Orai
  - tha
  - ned
  - mid
  - nes
  - egr
  - Hdl
  - modSP
  - Or33a
  - et
  - MKP-4
  - p38b
  - rl
  - Pal1
  - sdt
  - tf
  - Ir75a
  - by
  - snRNP-U1-C
  - Ace
  - Acer
  - Ance
  - Dif
  - dl
  - Rel
  - dor
  - DOR
  - COX2
  - Np
  - ea
  - TMAO
  - Statine
  - Biguanides
  - glucose
  - Cortisol
  - Serotonin
---
